[go: up one dir, main page]

IL135349A0 - Statin-carboxyalkylether combinations - Google Patents

Statin-carboxyalkylether combinations

Info

Publication number
IL135349A0
IL135349A0 IL13534998A IL13534998A IL135349A0 IL 135349 A0 IL135349 A0 IL 135349A0 IL 13534998 A IL13534998 A IL 13534998A IL 13534998 A IL13534998 A IL 13534998A IL 135349 A0 IL135349 A0 IL 135349A0
Authority
IL
Israel
Prior art keywords
carboxyalkylether
statin
combinations
carboxyalkylether combinations
Prior art date
Application number
IL13534998A
Other languages
English (en)
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Priority to IL15732598A priority Critical patent/IL157325A0/xx
Priority to IL15732498A priority patent/IL157324A0/xx
Priority to IL15659198A priority patent/IL156591A0/xx
Priority to IL15732398A priority patent/IL157323A0/xx
Publication of IL135349A0 publication Critical patent/IL135349A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
IL13534998A 1997-12-12 1998-11-20 Statin-carboxyalkylether combinations IL135349A0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
IL15732598A IL157325A0 (en) 1997-12-12 1998-11-20 A kit comprising a carboxyalkylether and a statin for achieving a therapeutic effect in treatment of hyperlipidemia and cardiac risk
IL15732498A IL157324A0 (en) 1997-12-12 1998-11-20 A synergistic pharmaceutical composition for managing cardiac risk comprising two components
IL15659198A IL156591A0 (en) 1997-12-12 1998-11-20 Combinations of statin and alkylether derivatives
IL15732398A IL157323A0 (en) 1997-12-12 1998-11-20 A synergistic pharmaceutical composition for achieving hypolipidemic effect comprising two components

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6937597P 1997-12-12 1997-12-12
PCT/US1998/024679 WO1999030704A1 (en) 1997-12-12 1998-11-20 Statin-carboxyalkylether combinations

Publications (1)

Publication Number Publication Date
IL135349A0 true IL135349A0 (en) 2001-05-20

Family

ID=22088573

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13534998A IL135349A0 (en) 1997-12-12 1998-11-20 Statin-carboxyalkylether combinations

Country Status (30)

Country Link
EP (1) EP1045691B1 (es)
JP (1) JP2002508320A (es)
KR (1) KR20010033003A (es)
AR (1) AR017851A1 (es)
AT (1) ATE285762T1 (es)
AU (1) AU754089B2 (es)
BR (1) BR9813542A (es)
CA (1) CA2304612A1 (es)
CO (1) CO4970816A1 (es)
CR (1) CR5926A (es)
CU (1) CU20000140A7 (es)
DE (1) DE69828442T2 (es)
DK (1) DK1045691T3 (es)
ES (1) ES2230733T3 (es)
GT (1) GT199800196A (es)
HN (1) HN1998000185A (es)
HU (1) HUP0004547A3 (es)
IL (1) IL135349A0 (es)
IS (1) IS2150B (es)
MY (1) MY118381A (es)
NO (1) NO20002966D0 (es)
NZ (1) NZ503982A (es)
PA (1) PA8464601A1 (es)
PE (1) PE20000017A1 (es)
PL (1) PL341066A1 (es)
PT (1) PT1045691E (es)
SV (1) SV1998000146A (es)
UY (1) UY25299A1 (es)
WO (1) WO1999030704A1 (es)
ZA (1) ZA9811348B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861555B2 (en) 2000-01-25 2005-03-01 Warner-Lambert Company Calcium dicarboxylate ethers, methods of making same, and treatment of vascular disease and diabetes therewith
CA2299397A1 (en) * 1997-12-12 1999-06-24 Warner-Lambert Company Antihyperlipidemic statin-lp(a) inhibitor combinations
US20030105154A1 (en) 2001-10-24 2003-06-05 Bisgaier Charles Larry Statin-carboxyalkylether combinations
EA007427B1 (ru) * 1998-09-30 2006-10-27 Варнер Ламберт Компани Способ предотвращения или отсрочки катетерной реваскуляризации
US6562864B1 (en) * 1999-09-02 2003-05-13 Drake Larson Catechin multimers as therapeutic drug delivery agents
IN191580B (es) * 1999-12-17 2003-12-06 Ranbaxy Lab Ltd
NZ519550A (en) 2000-01-25 2003-11-28 Warner Lambert Co Calcium dicarboxylate ethers, methods of making same, and treatment of vascular disease and diabetes therewith
WO2001078747A1 (de) * 2000-04-18 2001-10-25 Bayer Aktiengesellschaft Verwendung von cse-hemmern zur behandlung von herzinsuffizienz
AP2002002665A0 (en) * 2000-04-26 2002-12-31 Warner Lambert Co Antihypertensive agents and use.
US6689807B1 (en) * 2000-06-08 2004-02-10 Caritas St. Elizabeth's Medical Center Of Boston, Inc. HMG CoA reductase inhibitors for promoting angiogenesis
US6777552B2 (en) 2001-08-16 2004-08-17 Teva Pharmaceutical Industries, Ltd. Processes for preparing calcium salt forms of statins
CN100430405C (zh) * 2001-08-16 2008-11-05 特瓦制药工业有限公司 制备他汀类的钙盐形式的方法
US20050026979A1 (en) * 2003-07-31 2005-02-03 Maha Ghazzi Methods for treating inflammation and inflammation-associated diseases with a statin and ether
AU2013207423B2 (en) * 2012-01-06 2017-10-12 Gemphire Therapeutics Inc. Methods of reducing risk of cardiovascular disease
JP2018536710A (ja) 2015-11-06 2018-12-13 ジェンファイア・セラピューティクス・インコーポレイテッドGemphire Therapeutics Inc. 混合型脂質異常症の治療

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648387A (en) * 1995-03-24 1997-07-15 Warner-Lambert Company Carboxyalkylethers, formulations, and treatment of vascular diseases

Also Published As

Publication number Publication date
GT199800196A (es) 2000-06-03
CU20000140A7 (es) 2005-10-19
PA8464601A1 (es) 2001-12-14
HUP0004547A2 (hu) 2001-05-28
SV1998000146A (es) 1999-09-30
BR9813542A (pt) 2000-10-10
HN1998000185A (es) 1999-06-02
ES2230733T3 (es) 2005-05-01
IS5445A (is) 2000-04-14
ZA9811348B (en) 1999-06-14
WO1999030704A1 (en) 1999-06-24
NO20002966L (no) 2000-06-09
PT1045691E (pt) 2005-03-31
UY25299A1 (es) 2001-08-27
AU754089B2 (en) 2002-11-07
NO20002966D0 (no) 2000-06-09
MY118381A (en) 2004-10-30
KR20010033003A (ko) 2001-04-25
AU1591599A (en) 1999-07-05
HUP0004547A3 (en) 2001-12-28
CR5926A (es) 2000-03-06
DE69828442D1 (de) 2005-02-03
EP1045691A1 (en) 2000-10-25
JP2002508320A (ja) 2002-03-19
NZ503982A (en) 2002-03-28
AR017851A1 (es) 2001-10-24
CO4970816A1 (es) 2000-11-07
DK1045691T3 (da) 2005-03-14
DE69828442T2 (de) 2005-06-02
IS2150B (is) 2006-10-13
PE20000017A1 (es) 2000-01-20
ATE285762T1 (de) 2005-01-15
CA2304612A1 (en) 1999-06-24
PL341066A1 (en) 2001-03-26
EP1045691B1 (en) 2004-12-29

Similar Documents

Publication Publication Date Title
DE69817801D1 (en) Arylsulfonylhydroxamsäurederivate
IL124350A0 (en) Resorcinyl-triazines
DE69840493D1 (en) Tionseinlage
DE69810944D1 (en) Hydroperoxidzersetzungsverfahren
DE69832527D1 (en) Chronographenuhr
DE59808840D1 (en) Compoundpumpe
ZA9811348B (en) Statin-carboxyalkylether combinations
GB9709832D0 (en) Divineh
DE59803148D1 (en) Dimensionsstabile thermoplastische formmassen
DE69801658D1 (en) Polyurethanhartschaumstoffe
GB9712536D0 (en) Disc-retainer
GB9703543D0 (en) Vaso-belt
GB9703606D0 (en) Egg-cookers
GB2326623B (en) Prentensioner
DE69829970D1 (en) Implantsystem
DE59806884D1 (en) Dexamethason-gel
GB9721988D0 (en) Catch-pits
GB9708522D0 (en) Wordgame
GB9724908D0 (en) Ski-sling
EP1007678A4 (en) KRINGLE 1
DE69813798D1 (en) Multizyklische erythromycinderivate
GB2323262B (en) Snack-foods
GB9710841D0 (en) Lawnsaver
GB9706288D0 (en) Riggintag
CA82218S (en) Sports-glasses